Document is current

Any future updates will be listed below

Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel

Crossref DOI link: https://doi.org/10.1007/s12032-017-0884-7

Published Online: 2017-01-11

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark